Company
Royal Medical Center
Royal Medical Center publishes compounded semaglutide and compounded tirzepatide at $67 a month — Compounded GLP-1 program, starting price.
- 2 programs
- 2 molecules
- 2 readings
Read from royalmedicalcenters.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Royal Medical Center
We earn nothing from this link. Royal Medical Center has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Compounded GLP-1 program, starting price
first month, including the required fees on record · Compounded GLP-1 program, starting price
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. A single 'starting at $67/month' price is published for a combined tirzepatide-and-semaglutide compounded program; the page does not break the price out per drug, so the same figure was recorded against both. No page found stating served states, prescriber synchronicity, cancellation terms, or a membership fee — checked the men's FAQ, women's FAQ, weight-loss page, and HIPAA policy without finding any of these.
Before you act
Cite this
Treatment Registry. (2026). Royal Medical Center: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/royal-medical-center